[1]
2022. Re-Challenge with Sonidegib after Vismodegib Discontinuation in a Near- Centenarian Patient with Locally Advanced Basal Cell Carcinoma. Archives of Clinical and Medical Case Reports. 6, 5 (Sep. 2022), 636–638.